Connecticut 2016 Regular Session

Connecticut Senate Bill SB00353

Introduced
3/2/16  
Refer
3/2/16  
Report Pass
3/21/16  
Refer
3/29/16  
Report Pass
4/5/16  

Caption

An Act Concerning Opioid Use Disorder.

Impact

The enactment of SB00353 is expected to significantly impact state laws regarding substance use disorder and treatment protocols. By implementing standardized procedures and establishing clear responsibilities among health care providers, this bill seeks to enhance the efficiency and effectiveness of treatment for opioid disorders across Connecticut. Additionally, local police and emergency medical personnel will be empowered to connect individuals in need of help to appropriate resources, fostering community-based recovery initiatives.

Summary

SB00353, titled 'An Act Concerning Opioid Use Disorder', is designed to address the growing opioid crisis by establishing a comprehensive framework for treatment and prevention. The bill creates a Connecticut Alcohol and Drug Policy Council, composed of various stakeholders, to coordinate interagency efforts and develop an integrated plan for addressing substance use disorders. This initiative aims to enhance the state's response through data-driven strategies, public outreach, and tailored treatment services, particularly focusing on medication-assisted treatment and overdose prevention strategies.

Sentiment

General sentiment around SB00353 appears to be largely supportive, particularly among public health advocates and addiction specialists who see it as a necessary step toward combating the opioid epidemic. The council’s inclusive composition is also viewed favorably as it brings together diverse perspectives and expertise to tackle complex issues. However, there may be concerns regarding the adequacy of funding and resources to implement the proposed programs effectively.

Contention

While the bill has garnered positive responses, potential points of contention may arise concerning the logistics of implementing the proposed services, especially regarding the integration of various state agencies and community organizations in the opioid treatment framework. Additionally, ensuring that the council remains responsive to changing drug trends and maintains accountability for outcomes will be crucial to the success of the bill's initiatives.

Companion Bills

No companion bills found.

Similar Bills

CA SB1290

Substance abuse disorder treatment.

NJ S3955

Prohibits use of deceptive marketing practices by substance use disorder treatment providers.

NJ A3974

Prohibits use of deceptive marketing practices by substance use disorder treatment providers.

CA AB541

Tobacco assessment.

NJ A2972

Requires DHS to establish sobriety standards and drug testing requirements for substance use disorder treatment centers and to conduct both announced and unscheduled inspections.

CA AB2230

Tobacco assessment.

CA AB1031

Youth Substance Use Disorder Treatment and Recovery Program Act of 2019.

CA AB1098

Recovery residences.